Johanna Mylet is Chief Financial Officer of Poseida Therapeutics, Inc.. Currently has a direct ownership of 246,283 shares of PSTX, which is worth approximately $2.32 Million. The most recent transaction as insider was on Mar 01, 2024, when has been sold 18,091 shares (Common Stock) at a price of $4.13 per share, resulting in proceeds of $74,715. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 246K
0% 3M change
38.65% 12M change
Total Value Held $2.32 Million

Johanna Mylet Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 01 2024
SELL
Payment of exercise price or tax liability
$74,715 $4.13 p/Share
18,091 Reduced 6.84%
246,283 Common Stock
Mar 01 2024
BUY
Grant, award, or other acquisition
-
80,743 Added 23.4%
264,374 Common Stock
Mar 01 2023
SELL
Payment of exercise price or tax liability
$23,128 $5.35 p/Share
4,323 Reduced 2.38%
177,631 Common Stock
Mar 01 2023
BUY
Grant, award, or other acquisition
-
92,772 Added 33.77%
181,954 Common Stock
Mar 01 2022
BUY
Grant, award, or other acquisition
-
50,000 Added 37.25%
84,231 Common Stock
Dec 21 2021
BUY
Exercise of conversion of derivative security
$8,860 $1.55 p/Share
5,716 Added 14.31%
34,231 Common Stock
Jan 15 2021
BUY
Exercise of conversion of derivative security
$1,418 $0.3 p/Share
4,728 Added 14.99%
26,813 Common Stock
JM

Johanna Mylet

Chief Financial Officer
San Diego, CA

Track Institutional and Insider Activities on PSTX

Follow Poseida Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PSTX shares.

Notify only if

Insider Trading

Get notified when an Poseida Therapeutics, Inc. insider buys or sells PSTX shares.

Notify only if

News

Receive news related to Poseida Therapeutics, Inc.

Track Activities on PSTX